BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35483078)

  • 1. Value of Diffusion-Weighted Imaging and Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Prediction of Treatment Outcomes in Nasopharyngeal Carcinoma.
    Paprad T; Lertbutsayanukul C; Jittapiromsak N
    J Comput Assist Tomogr; 2022 Jul-Aug 01; 46(4):664-672. PubMed ID: 35483078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of dynamic contrast-enhanced magnetic resonance imaging for determining the plasma Epstein-Barr virus status and staging of nasopharyngeal carcinoma.
    Sriyook A; Lertbutsayanukul C; Jittapiromsak N
    Clin Imaging; 2021 Apr; 72():1-7. PubMed ID: 33190027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the pre-treatment functional MRI metrics' efficacy in predicting Locoregionally advanced nasopharyngeal carcinoma response to induction chemotherapy.
    Zhao DW; Fan WJ; Meng LL; Luo YR; Wei J; Liu K; Liu G; Li JF; Zang X; Li M; Zhang XX; Ma L
    Cancer Imaging; 2021 Nov; 21(1):59. PubMed ID: 34758876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative Analysis of DCE-MRI and RESOLVE-DWI for Differentiating Nasopharyngeal Carcinoma from Nasopharyngeal Lymphoid Hyperplasia.
    Yu JY; Zhang D; Huang XL; Ma J; Yang C; Li XJ; Xiong H; Zhou B; Liao RK; Tang ZY
    J Med Syst; 2020 Feb; 44(4):75. PubMed ID: 32103352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of intravoxel incoherent motion and dynamic contrast-enhanced MRI for predicting the early and short-term responses to chemoradiotherapy in nasopharyngeal carcinoma.
    Hou J; Yu X; Hu Y; Li F; Xiang W; Wang L; Wang H; Lu Q; Zhang Z; Zeng W
    Medicine (Baltimore); 2016 Aug; 95(35):e4320. PubMed ID: 27583847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative dynamic contrast-enhanced and diffusion-weighted MRI for differentiation between nasopharyngeal carcinoma and lymphoma at the primary site.
    Yu XP; Hou J; Li FP; Xiang W; Lu Q; Hu Y; Wang H
    Dentomaxillofac Radiol; 2016; 45(3):20150317. PubMed ID: 26846711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential diagnosis of nasopharyngeal carcinoma and nasopharyngeal lymphoma based on DCE-MRI and RESOLVE-DWI.
    Song C; Cheng P; Cheng J; Zhang Y; Sun M; Xie S; Zhang X
    Eur Radiol; 2020 Jan; 30(1):110-118. PubMed ID: 31372786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of diffusion-weighted imaging and arterial spin labeling at 3.0 T for the clinical staging of nasopharyngeal carcinoma.
    Xiao B; Wang P; Zhao Y; Liu Y; Ye Z
    Clin Imaging; 2020 Oct; 66():127-132. PubMed ID: 32480267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic contrast-enhanced MRI predicts PTEN protein expression which can function as a prognostic measure of progression-free survival in NPC patients.
    Wu G; Huang W; Xu J; Li W; Wu Y; Yang Q; Liu K; Zhu M; Balasubramanian PS; Li M
    J Cancer Res Clin Oncol; 2022 Jul; 148(7):1771-1780. PubMed ID: 34398299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic Resonance Imaging Features on Deep Learning Algorithm for the Diagnosis of Nasopharyngeal Carcinoma.
    Huang R; Zhou Z; Wang X; Cao X
    Contrast Media Mol Imaging; 2022; 2022():3790269. PubMed ID: 35677026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic Contrast-Enhanced MRI Parameters and Normalized ADC Values Could Aid Differentiation of Skull Base Osteomyelitis from Nasopharyngeal Cancer.
    Baba A; Kurokawa R; Kurokawa M; Ota Y; Srinivasan A
    AJNR Am J Neuroradiol; 2023 Jan; 44(1):74-78. PubMed ID: 36521963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of pretreatment tumor apparent diffusion coefficient values in nasopharyngeal carcinoma.
    Yan DF; Zhang WB; Ke SB; Zhao F; Yan SX; Wang QD; Teng LS
    BMC Cancer; 2017 Oct; 17(1):678. PubMed ID: 29020937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinguishing T1-2 and T3a tumors of rectal cancer with texture analysis and functional MRI parameters.
    Sun D; Wu X; Wang L; Li G; Huang J; Li Y
    Diagn Interv Radiol; 2022 May; 28(3):200-207. PubMed ID: 35748201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating dynamic contrast-enhanced magnetic resonance imaging and diffusion kurtosis imaging for neoadjuvant chemotherapy assessment of nasopharyngeal carcinoma.
    Zheng D; Lai G; Chen Y; Yue Q; Liu X; Chen X; Chen W; Chan Q; Chen Y
    J Magn Reson Imaging; 2018 Nov; 48(5):1208-1216. PubMed ID: 29693765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The therapeutic utility of combining dynamic contrast-enhanced magnetic resonance imaging with arterial spin labeling in the staging of nasopharyngeal carcinoma.
    Li H; Gong G; Wang L; Su Y; Lu J; Yin Y
    BMC Med Imaging; 2023 May; 23(1):61. PubMed ID: 37138205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic contrast-enhanced MRI of nasopharyngeal carcinoma: correlation of quantitative dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) parameters with hypoxia-inducible factor 1α expression and tumor grade/stage.
    Liu L; Hu L; Zeng Q; Peng D; Chen Z; Huang C; Liu Z; Wen Q; Zou F; Yan L
    Ann Palliat Med; 2021 Feb; 10(2):2238-2253. PubMed ID: 33725777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amide proton transfer (APT) and magnetization transfer (MT) in predicting short-term therapeutic outcome in nasopharyngeal carcinoma after chemoradiotherapy: a feasibility study of three-dimensional chemical exchange saturation transfer (CEST) MRI.
    Liu W; Wang X; Xie S; Liu WV; Masokano IB; Bai Y; Chen J; Zhong L; Luo Y; Zhou G; Li W; Pei Y
    Cancer Imaging; 2023 Sep; 23(1):80. PubMed ID: 37658446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship between parameters of dynamic contrast-enhanced MRI and clinical stage of nasopharyngeal carcinoma].
    Yu X; Li F; Hu Y; Lu Q; Wang H
    Zhonghua Zhong Liu Za Zhi; 2015 Aug; 37(8):597-602. PubMed ID: 26714600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion-weighted magnetic resonance imaging for early response assessment of chemoradiotherapy in patients with nasopharyngeal carcinoma.
    Chen Y; Liu X; Zheng D; Xu L; Hong L; Xu Y; Pan J
    Magn Reson Imaging; 2014 Jul; 32(6):630-7. PubMed ID: 24703576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of the response of ocular adnexal lymphoma to chemotherapy using combined pretreatment dynamic contrast-enhanced and diffusion-weighted MRI.
    Guo P; Liu Z; Yan F; Wang J; Wei L; Lv H; Wang Z; Xian J
    Acta Radiol; 2016 Dec; 57(12):1490-1496. PubMed ID: 27012277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.